Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.
about
Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics.High dose of antibiotic colistin induces oligomerization of molecular chaperone HSP90.Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection.Preparation and characterisation of the colistin-entrapped liposome driven by electrostatic interaction for intravenous administration.Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa.
P2860
Q38340865-2BCB93DB-D93E-4AD2-8913-C6558EE16187Q39031123-DB4C9A0A-CF7B-4C33-93D3-8D58D342EBA0Q39414836-9DE66B6D-5767-4C56-AB10-BB78B794FC63Q40332075-61423991-8751-4330-8C46-FBB375150902Q40558076-919129B0-FBEF-4E14-90E0-CF55303731EFQ40621875-EA7CBF37-4640-4E68-9905-C02265247D92Q50052264-A4A1335D-5DCA-4320-9465-B2594AAE3E77
P2860
Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Interaction of colistin and co ...... implications for formulation.
@ast
Interaction of colistin and co ...... implications for formulation.
@en
type
label
Interaction of colistin and co ...... implications for formulation.
@ast
Interaction of colistin and co ...... implications for formulation.
@en
prefLabel
Interaction of colistin and co ...... implications for formulation.
@ast
Interaction of colistin and co ...... implications for formulation.
@en
P2093
P2860
P356
P1476
Interaction of colistin and co ...... d implications for formulation
@en
P2093
Richard J Prankerd
Roger L Nation
Stephanie J Wallace
P2860
P304
P356
10.1002/JPS.23203
P407
P577
2012-05-23T00:00:00Z